334 related articles for article (PubMed ID: 23464690)
41. Managing the breast in patients who test positive for hereditary breast cancer.
Euhus D
Ann Surg Oncol; 2012 Jun; 19(6):1738-44. PubMed ID: 22395981
[TBL] [Abstract][Full Text] [Related]
42. Genetics: breast cancer as an exemplar.
Hamilton R
Nurs Clin North Am; 2009 Sep; 44(3):327-38. PubMed ID: 19683094
[TBL] [Abstract][Full Text] [Related]
43. Clinical management of hereditary breast cancer syndromes.
Clark AS; Domchek SM
J Mammary Gland Biol Neoplasia; 2011 Apr; 16(1):17-25. PubMed ID: 21360002
[TBL] [Abstract][Full Text] [Related]
44. Hereditary breast cancer syndromes and genetic testing.
Rich TA; Woodson AH; Litton J; Arun B
J Surg Oncol; 2015 Jan; 111(1):66-80. PubMed ID: 25381882
[TBL] [Abstract][Full Text] [Related]
45. Identifying hereditary cancer: genetic counseling and cancer risk assessment.
Lewis KM
Curr Probl Cancer; 2014; 38(6):216-25. PubMed ID: 25432528
[TBL] [Abstract][Full Text] [Related]
46. Management of hereditary breast cancer. European Familial Breast Cancer Collaborative Group.
Eccles DM; Simmonds P; Goddard J; Coultas M; Lalloo F; Evans G; Haites N
Dis Markers; 1999 Oct; 15(1-3):187-9. PubMed ID: 10595276
[No Abstract] [Full Text] [Related]
47. Genetic counseling for breast cancer.
Clark S; Iglehart JD
Adv Surg; 1999; 33():199-215. PubMed ID: 10572568
[No Abstract] [Full Text] [Related]
48. Diagnosis and Management of Hereditary Renal Cell Cancer.
Menko FH; Maher ER
Recent Results Cancer Res; 2016; 205():85-104. PubMed ID: 27075350
[TBL] [Abstract][Full Text] [Related]
49. Recognition and management of hereditary breast cancer syndromes.
Thull DL; Vogel VG
Oncologist; 2004; 9(1):13-24. PubMed ID: 14755011
[TBL] [Abstract][Full Text] [Related]
50. Breast Cancer Genetics for the Surgeon: An Update on Causes and Testing Options.
Grignol VP; Agnese DM
J Am Coll Surg; 2016 May; 222(5):906-14. PubMed ID: 26968323
[No Abstract] [Full Text] [Related]
51. Management of women who have a genetic predisposition for breast cancer.
Jatoi I; Anderson WF
Surg Clin North Am; 2008 Aug; 88(4):845-61, vii-viii. PubMed ID: 18672143
[TBL] [Abstract][Full Text] [Related]
52. Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome.
Obstet Gynecol; 2017 Sep; 130(3):e110-e126. PubMed ID: 28832484
[TBL] [Abstract][Full Text] [Related]
53. Management of women with a hereditary predisposition for breast cancer.
Jatoi I; Benson JR
Future Oncol; 2016 Oct; 12(19):2277-88. PubMed ID: 27384952
[TBL] [Abstract][Full Text] [Related]
54. Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?
Stoppa-Lyonnet D; Caligo M; Eccles D; Evans DG; Haites NE; Hodgson NS; Møller P; Morrison PJ; Steel CM; Vasen HF; Chang-Claude J
Dis Markers; 1999 Oct; 15(1-3):67-8. PubMed ID: 10595254
[No Abstract] [Full Text] [Related]
55. National Distribution of Cancer Genetic Testing in the United States: Evidence for a Gender Disparity in Hereditary Breast and Ovarian Cancer.
Childers KK; Maggard-Gibbons M; Macinko J; Childers CP
JAMA Oncol; 2018 Jun; 4(6):876-879. PubMed ID: 29710084
[TBL] [Abstract][Full Text] [Related]
56. [Personalized medicine and breast cancer: anticipatory medicine, prognostic evaluation and therapeutic targeting].
Gonçalves A; Moretta J; Eisinger F; Bertucci F
Bull Cancer; 2013 Dec; 100(12):1295-310. PubMed ID: 24225763
[TBL] [Abstract][Full Text] [Related]
57. [Usefulness of the oncogenetic molecular counselling in adults whith familial cancer].
Valdespino-Gómez VM; Valdespino-Castillo VE
Rev Med Inst Mex Seguro Soc; 2016; 54(3):364-74. PubMed ID: 27100983
[TBL] [Abstract][Full Text] [Related]
58. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
Daly MB; Pilarski R; Yurgelun MB; Berry MP; Buys SS; Dickson P; Domchek SM; Elkhanany A; Friedman S; Garber JE; Goggins M; Hutton ML; Khan S; Klein C; Kohlmann W; Kurian AW; Laronga C; Litton JK; Mak JS; Menendez CS; Merajver SD; Norquist BS; Offit K; Pal T; Pederson HJ; Reiser G; Shannon KM; Visvanathan K; Weitzel JN; Wick MJ; Wisinski KB; Dwyer MA; Darlow SD
J Natl Compr Canc Netw; 2020 Apr; 18(4):380-391. PubMed ID: 32259785
[TBL] [Abstract][Full Text] [Related]
59. [The Supreme Court free genes - economic and legal justifications - impacts on innovation and the healthcare offer].
Cassier M; Stoppa-Lyonnet D
Med Sci (Paris); 2015 Feb; 31(2):209-13. PubMed ID: 25744269
[No Abstract] [Full Text] [Related]
60. Risk assessment, genetic counseling, and clinical care for hereditary breast cancer.
Powers J; Stopfer JE
J Obstet Gynecol Neonatal Nurs; 2014; 43(3):361-73. PubMed ID: 24689498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
